We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PTAB Reverses Decision, Grants Inter Partes Review of Herceptin Patent
PTAB Reverses Decision, Grants Inter Partes Review of Herceptin Patent
The PTO’s Patent Trials and Appeals Board reversed course last week, granting inter partes review of a Herceptin patent that it previously refused, following challenges from Hospira.